| Company Name: |
SPIRO PHARMA |
| Tel: |
|
| Email: |
eric_feng1954@126.com |
|
| | Cytidine, N-benzoyl-2^-deoxy-2^-oxo-3^,5^-O-[1,1,3,3-tetrakis(1-Methylethyl)-1,3-disiloxanediyl]- Basic information |
| Product Name: | Cytidine, N-benzoyl-2^-deoxy-2^-oxo-3^,5^-O-[1,1,3,3-tetrakis(1-Methylethyl)-1,3-disiloxanediyl]- | | Synonyms: | Cytidine, N-benzoyl-2^-deoxy-2^-oxo-3^,5^-O-[1,1,3,3-tetrakis(1-Methylethyl)-1,3-disiloxanediyl]-;N-(2-oxo-1-((6aR,8R,9aR)-2,2,4,4-tetraisopropyl-9-oxotetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl)-1,2-dihydropyrimidin-4-yl)benzamide | | CAS: | 119411-03-9 | | MF: | C28H41N3O7Si2 | | MW: | 587.81 | | EINECS: | | | Product Categories: | | | Mol File: | 119411-03-9.mol | ![Cytidine, N-benzoyl-2^-deoxy-2^-oxo-3^,5^-O-[1,1,3,3-tetrakis(1-Methylethyl)-1,3-disiloxanediyl]- Structure](CAS/20180808/GIF/119411-03-9.gif) |
| | Cytidine, N-benzoyl-2^-deoxy-2^-oxo-3^,5^-O-[1,1,3,3-tetrakis(1-Methylethyl)-1,3-disiloxanediyl]- Chemical Properties |
| | Cytidine, N-benzoyl-2^-deoxy-2^-oxo-3^,5^-O-[1,1,3,3-tetrakis(1-Methylethyl)-1,3-disiloxanediyl]- Usage And Synthesis |
| | Cytidine, N-benzoyl-2^-deoxy-2^-oxo-3^,5^-O-[1,1,3,3-tetrakis(1-Methylethyl)-1,3-disiloxanediyl]- Preparation Products And Raw materials |
| Raw materials | N4-Benzoyl-3',5'-O-(1,1,3,3-tetraisopropyl-1,3-disiloxanediyl)cytidine | | Preparation Products | BenzaMide, N-[1,2-dihydro-1-(2-C-Methyl-β-D-arabinofuranosyl)-2-oxo-4-pyriMidinyl]--->BenzaMide, N-[1,2-dihydro-1-[2-C-Methyl-3,5-O-[1,1,3,3-tetrakis(1-Methylethyl)-1,3-disiloxanediyl]-β-D-arabinofuranosyl]-2-oxo-4-pyriMidinyl]- |
|